{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fquadshot-news-podcast.simplecast.com%2Fepisodes%2F10302023-conjugate-risk-eUn_Cvi7","width":444,"version":"1.0","type":"rich","title":"10.30.2023 - Conjugate Risk","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/d4956b26-f7a3-4f47-a83d-9293649d65c8/ec08e780-4e06-4c01-8109-4e894d682296/qs_sqaure.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/48850e48-e397-4210-9432-343c099f430b\" height=\"200\" width=\"100%\" title=\"10.30.2023 - Conjugate Risk\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Check out this week's QuadCast as we highlight the risk of using antibody drug conjugates with brain SRS, 5 fraction APBI on consecutive days, a better way to classify perineural invasion, and more."}